Keywords
L-asparaginase
Adult
Acute lymphoblastic leukemia
Submitted : 2023-08-26
Accepted : 2023-09-10
Published : 2023-09-25
Abstract
Objective: To compare the effect of L-asparaginase and pegaspargase in the treatment of adult acute lymphoblastic leukemia. Methods: In this study, 96 patients who received treatment at the Shaanxi Provincial People’s Hospital from April 2019 to April 2021 were selected. The control group received L-asparaginase treatment, and the observation group received pegaspargase treatment. The curative effect and adverse reaction rate were compared between the two groups. Results: Comparing the experimental statistical results of the observation and the control groups, it can be concluded that the effect of the former group is better than that of the latter group in terms of clinical curative effect and statistics of adverse reactions. Conclusion: In the treatment of adult acute lymphoblastic leukemia, the application of pegaspargase therapy has a significantly better clinical effect and is worthy of further promotion.
References
Zhang C, Huang Y, 2020, Effects of Different Asparaginases Combined With Chemotherapy on the Incidence of Drug-Induced Diabetes in Children With Acute Lymphoblastic Leukemia. Chinese Primary Medicine, 27(22): 2730–2735.
Zhang N, Safety, Effectiveness and Economic Evaluation of Pegaspargase and L-Asparaginase in the Treatment of Newly Diagnosed Patients With Acute Lymphoblastic Leukemia. 2022, Chongqing Medical University.
Chen N, Song C, Jing Y, et al., 2021, The Short-Term Effects of Two Kinds of Asparaginases in the Treatment of Acute Lymphoblastic Leukemia in Children and Their Effects on Serum LDH, SF and ESR in Children. Journal of Practical Cancer, 36(2): 337–340.
Hou X, Jin R, Xie Y, et al., 2020, The Therapeutic Effect of Pegaspargase on Children With Acute Lymphoblastic Leukemia and Its Effect on Blood Coagulation. Cancer Progress, 18(17): 1813–1816 + 1835.
Zhao X, Wang Z, Zhuang Y, et al., 2020, Comparison of Curative Effect and Laboratory Indicators of L-Asparaginase and Pegaspargase in the Treatment of Children With Acute Lymphoblastic Leukemia. Pediatric Pharmaceutical Journal, 26(10): 17–20.
Zhan S, Zhang L, Huang Z, et al., 2020, Study on Adverse Reactions of L-Asparaginase and Pegaspargase in the Treatment of Children With Acute Lymphoblastic Leukemia. Chinese Drug Evaluation, 37(1): 50–54.
Li Y, Zhang L, Liu Y, et al., 2021, Clinical Research on the Effect of L-Asparaginase Combined With Chemotherapy on Blood Sugar and Immune Function in Children With Acute Lymphoblastic Leukemia. Journal of Practical Cancer, 36(8): 1386–1390.
Xiang J, Wang G, Bu F, 2022, Comparison of the Effects of L-Asparaginase and Pegaspargase in the Treatment of Children With Acute Lymphoblastic Leukemia. China Practical Medical Journal, 49(7): 113–115.
Han Y, Zhang S, Yang Y, 2021, Discussion on the Safety of High-Dose Asparaginase in the Treatment of Acute Lymphoblastic Leukemia in Children. Chinese Medicine Guide, 2021(33): 7–9.